EGFR mutation unique to glioblastoma linked to lack of response

Use of neutrophils to prevent lung metastases in breast cancer patients

Antiangiogenic therapies for non-small cell lung cancer

Cellular pathways in lung cancer and the need for personalised medicine

The evolving role of immunotherapy in oncology

Latest in renal carcinoma

Use of circulating tumour cells as a prognostic or predictive marker

Message from the President-Elect of ESTRO

Advances in the treatment of lung cancer and melanoma

Roundup of the EMCC 2011 conference

Development of a lung cancer blood test

Future for immunotherapies